ESC Professional Premium Access

Reversal agents to improve safety in patients treated with antiplatelet P2Y12 inhibitors.

Congress Session

About the speaker

Professor Deepak Bhatt

Harvard Medical School, Boston (United States of America)
36 presentations
2 followers

5 more presentations in this session

Reversal agents to improve safety in patients treated with direct oral anticoagulants (DOACs).

Speaker: Associate Professor A. Niessner (Vienna, AT)

Thumbnail

P2Y12 inhibitor monotherapy in patients undergoing PCI.

Speaker: Doctor D. Angiolillo (Jacksonville, US)

Thumbnail

Injectable and intravenous P2Y12 inhibitors in patients with acute myocardial infarction.

Speaker: Professor G. Montalescot (Paris, FR)

Thumbnail

Factor XIa inhibitors: a new approach to anticoagulation in patients with cardiovascular disease.

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Problem-solving in antiplatelet therapy and anticoagulation – discussion.

Thumbnail

Access the full session

Problem-solving in antiplatelet therapy and anticoagulation

Speakers: Professor D. Bhatt, Associate Professor A. Niessner, Doctor D. Angiolillo, Professor G. Montalescot, Doctor J. Weitz
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk